MediciNova, Inc. to Receive $2.5 Million Payment From Kissei Pharmaceutical Co., Ltd. to Expand Clinical Development of the MN-221 Program
10/14/2011 7:20:55 AM
More...
|
MediciNova, Inc. Announces Private Sale of Stock to Kissei Pharmaceutical Co., Ltd.
9/27/2011 10:21:39 AM
More...
|
SpePharm Sells Japanese Rights for Savene(R) to Kissei Pharmaceutical Co., Ltd.
9/1/2011 10:08:01 AM
More...
|
Protox Therapeutics Inc. (PRX.V) Signs $75 Million License Agreement with Kissei Pharmaceutical Co., Ltd. for Commercialization of PRX302 in Japan for BPH and Prostate Disease
4/29/2010 2:58:46 PM
More...
|
Kissei Pharmaceutical Co., Ltd. Announces New Drug Application for Silodosin has been Filed with FDA
2/13/2008 12:27:33 PM
More...
|
Nuon Therapeutics Inc. Completes Licensing, Supply and Collaboration Agreement on Tranilast With Kissei Pharmaceutical Co., Ltd.
7/23/2007 11:14:19 AM
More...
|
Kissei Pharmaceutical Co., Ltd. and Eisai Company, Ltd. (ESALY.PK) Sign a License Agreement to Develop and Commercialize Glufast(R), a Rapid-acting Insulin Secretagogue in 10 ASEAN Countries
6/13/2007 1:14:56 PM
More...
|
Kissei Pharmaceutical Co., Ltd. And Daiichi Pharmaceutical (JPN) Jointly Launch Urination Disorder Improving Drug
5/12/2006 1:25:21 PM
More...
|
Kissei Pharmaceutical Co., Ltd. To License KGA, Diabetes Drug Candidate, To GlaxoSmithKline (GSK)
4/10/2006 12:23:19 PM
More...
|
Kissei Pharmaceutical Co., Ltd. Obtains Manufacturing Approval For URIEF Capsule, Benign Prosatic Hypertrophy Drug
1/24/2006 11:27:08 AM
More...
|
|